Stay updated with breaking news from Graphite Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Graphite Bio, Inc. (GRPH), a clinical-stage gene editing company, on Wednesday announced that it has entered into a definitive merger agreement with LENZ Therapeutics in an all-stock transaction.
By Dean Seal Graphite Bio has agreed to merge with LENZ Therapeutics in an all-stock transaction. The clinical-stage gene editing company and LENZ said...
GRPH | Complete Graphite Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
By Dean Seal Shares of Graphite Bio retreated after the company said it would merge with LENZ Therapeutics in an all-stock transaction. The stock was down 8%...
Healthpeak Properties, Inc. , a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the third quarter ended September 30,...